Synopsys CFO Shelagh Glaser Buys Shares

Shelagh Glaser, CFO of Synopsys, Inc., purchased 1,259 shares on June 15, 2026.

Editorial illustration for Synopsys, Inc. (SNPS)

Key Points

  • Synopsys CFO Shelagh Glaser purchased 1,259 shares of the company on June 15, 2026, at no cost per share.
  • Synopsys, Inc. trades at $454.38 with a market cap of $87 billion and a P/E ratio of 104.22.
  • Analysts have a consensus 'buy' rating with a mean price target of $560.38 for Synopsys.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Shelagh Glaser, the Chief Financial Officer of Synopsys, Inc. (NasdaqGS: SNPS), recently made a move to increase her stake in the company. On June 15, 2026, Glaser acquired 1,259 shares of Synopsys. The transaction was coded as "M," indicating it might have been part of an employee stock plan, as the shares were acquired at no cost.

Insider Buying and Selling at Synopsys, Inc.

In addition to Glaser's purchase, several other insiders engaged in transactions on the same day. Sudhindra Kankanwadi, Deputy CFO & CAO, bought 720 shares, while Janet Lee, General Counsel & Corporate Secretary, acquired 540 shares. On the selling side, Aart de Geus, Executive Chair, sold 449 shares, and Sassine Ghazi, President and CEO, sold 14,603 shares.

Synopsys, Inc. Stock Up 1.3%

Shares of Synopsys, Inc. are trading near $454.38. The company, with a market cap of approximately $87 billion, has a P/E ratio of 104.22 and a forward P/E of 26.34. Synopsys has a beta of 1.214, reflecting its volatility compared to the market. The stock's 52-week range is between $376.18 and $651.73, with moving averages of $476.05 for 50 days and $461.68 for 200 days.

Year to date

$SNPS stock price

Daily closing prices, year to date. Not investment advice.

Analysts Set New Price Targets

On May 28, 2026, several analysts shared their views on Synopsys. Citigroup maintained a 'buy' rating with a $610 price target. Stifel and B of A Securities also upheld their 'buy' ratings, targeting $600. Meanwhile, BNP Paribas maintained a 'sell' rating with a $450 target, and Wells Fargo held a 'hold' rating with a $535 target. The consensus among analysts is a 'buy,' with a mean target price of $560.38.

About Synopsys, Inc.

Synopsys, Inc., based in Sunnyvale, California, is a leading provider of design IP solutions for the semiconductor and electronics industries. The company operates in two main segments: Design Automation and Design IP. It offers a range of solutions, including digital and custom IC design, verification, and prototyping tools, as well as AI-driven EDA solutions. Synopsys collaborates strategically with Arm Holdings plc on CPU development, further enhancing its product offerings.

Bottom Line

Shelagh Glaser's recent share purchase underscores her commitment to Synopsys, a key player in the technology sector. The company's robust market position and diverse offerings in design IP and semiconductor solutions make it a noteworthy entity in the industry. While the insider transactions provide some insight, they are backward-looking and should be considered as part of a broader investment analysis.

Get Synopsys, Inc. alerts

New 13F filings, insider trades, and analyst moves on $SNPS, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.